Related references
Note: Only part of the references are listed.ILAE definition of the Idiopathic Generalized Epilepsy Syndromes: Position statement by the ILAE Task Force on Nosology and Definitions
Edouard Hirsch et al.
EPILEPSIA (2022)
PERMIT study: a global pooled analysis study of the effectiveness and tolerability of perampanel in routine clinical practice
Vicente Villanueva et al.
JOURNAL OF NEUROLOGY (2022)
Psychobehavioural and Cognitive Adverse Events of Anti-Seizure Medications for the Treatment of Developmental and Epileptic Encephalopathies
Adam Strzelczyk et al.
CNS DRUGS (2022)
Efficacy and safety of perampanel in epilepsy: A systematic review and meta-analysis of randomised controlled trials
Alekhya Lavu et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2022)
Long-term open-label perampanel: Generalized tonic-clonic seizures in idiopathic generalized epilepsy
Jacqueline A. French et al.
EPILEPSIA OPEN (2022)
Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs Introduction
Anthony G. Marson et al.
HEALTH TECHNOLOGY ASSESSMENT (2021)
The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial
Anthony Marson et al.
LANCET (2021)
Therapeutic Options for Childhood Absence Epilepsy
Victoria Elisa Rinaldi et al.
PEDIATRIC REPORTS (2021)
Pregabalin as adjunctive therapy in adult and pediatric patients with generalized tonic-clonic seizures: A randomized, placebo-controlled trial
Joseph Driscoll et al.
EPILEPSIA OPEN (2021)
Safety and tolerability of adjunctive brivaracetam in epilepsy: In-depth pooled analysis
Christian Brandt et al.
EPILEPSY & BEHAVIOR (2020)
30 years of second -generation antiseizure medications: impact and future perspectives
Emilio Perucca et al.
LANCET NEUROLOGY (2020)
Have new antiseizure medications improved clinical care over the past 30 years?
Jacqueline A. French et al.
LANCET NEUROLOGY (2020)
Temporal trends and autopsy findings of SUDEP based on medico-legal investigations in the United States
Esma Cihan et al.
NEUROLOGY (2020)
Adjunctive perampanel and myoclonic and absence seizures: Post hoc analysis of data from study 332 in patients with idiopathic generalized epilepsy
Christian Brandt et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2020)
Efficacy and safety of adjunctive lacosamide in the treatment of primary generalised tonic-clonic seizures: a double-blind, randomised, placebo-controlled trial
David G. Vossler et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2020)
RoB 2: a revised tool for assessing risk of bias in randomised trials
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Behavior Problems in Childhood Absence Epilepsy: A Chicken or Egg Problem
Jay Salpekar
EPILEPSY CURRENTS (2018)
Second monotherapy in childhood absence epilepsy
Avital Cnaan et al.
NEUROLOGY (2017)
Anti epileptic drug trials for patients with drug resistant idiopathic generalised epilepsy: A meta-analysis
Niamh Colleran et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2017)
Pretreatment behavior and subsequent medication effects in childhood absence epilepsy
Ruth C. Shinnar et al.
NEUROLOGY (2017)
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
Brian Hutton et al.
ANNALS OF INTERNAL MEDICINE (2015)
Adverse effects and safety profile of perampanel: A review of pooled data
Fergus Rugg-Gunn
EPILEPSIA (2014)
Conceptual and Technical Challenges in Network Meta-analysis
Andrea Cipriani et al.
ANNALS OF INTERNAL MEDICINE (2013)
Systematic Review and Meta-Analysis of the Efficacy and Safety of Perampanel in the Treatment of Partial-Onset Epilepsy
Warrington W. Q. Hsu et al.
CNS DRUGS (2013)
Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes
Tracy Glauser et al.
EPILEPSIA (2013)
Efficacy and tolerability of lamotrigine in Juvenile Myoclonic Epilepsy in adults: A prospective, unblinded randomized controlled trial
Rene Andrade Machado et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2013)
Long-term effectiveness of ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy
Hee Hwang et al.
BRAIN & DEVELOPMENT (2012)
Treatment of idiopathic generalized epilepsy - a review of the evidence
Ahmad Beydoun et al.
EXPERT OPINION ON PHARMACOTHERAPY (2012)
Predicting the extent of heterogeneity in meta-analysis, using empirical data from the Cochrane Database of Systematic Reviews
Rebecca M. Turner et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2012)
A multicenter, randomized, placebo-controlled trial of levetiracetam in children and adolescents with newly diagnosed absence epilepsy
Cinzia Fattore et al.
EPILEPSIA (2011)
Incidence and classification of new-onset epilepsy and epilepsy syndromes in children in Olmsted County, Minnesota from 1980 to 2004: A population-based study
Elaine C. Wirrell et al.
EPILEPSY RESEARCH (2011)
Adjunctive lamotrigine XR for primary generalized tonic-clonic seizures in a randomized, placebo-controlled study
Victor Biton et al.
EPILEPSY & BEHAVIOR (2010)
Ethosuximide, Valproic Acid, and Lamotrigine in Childhood Absence Epilepsy.
Tracy A. Glauser et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Pharmacotherapy of idiopathic generalized epilepsies
Paolo Curatolo et al.
EXPERT OPINION ON PHARMACOTHERAPY (2009)
A Randomized Open-Label Comparison of Lamotrigine and Valproate in Patients with Juvenile Myoclonic Epilepsy
M.R.A. Nikpour et al.
International Journal of Pharmacology (2009)
Levetiracetam in absence epilepsy
Alberto Verrotti et al.
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2008)
Levetiracetam for the treatment of idiopathic generalized epilepsy with myoclonic seizures
S. Noachtar et al.
NEUROLOGY (2008)
Placebo-controlled study of levetiracetam in idiopathic generalized epilepsy
S. F. Berkovic et al.
NEUROLOGY (2007)
Topiramate or valproate in patients with juvenile myoclonic epilepsy: A randomized open-label comparison
Paul M. Levisohn et al.
EPILEPSY & BEHAVIOR (2007)
The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial
Anthony G. Marson et al.
LANCET (2007)
Double-blind, placebo-controlled study of lamotrigine in primary generalized tonic-clonic seizures
V Biton et al.
NEUROLOGY (2005)
Epidemiology of idiopathic generalized epilepsies
P Jallon et al.
EPILEPSIA (2005)
Lamotrigine versus valproic acid as first-line monotherapy in newly diagnosed typical absence seizures: An open-label, randomized, parallel-group study
G Coppola et al.
EPILEPSIA (2004)
Combination of direct and indirect evidence in mixed treatment comparisons
G Lu et al.
STATISTICS IN MEDICINE (2004)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Share Paper
